Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. O‘Connor, T. Carroll, G. O‘Brien, N.G. McElvaney (Dublin, Ireland). Trends in diagnosis and clinical presentation of alpha-1 antitrypsin deficiency within an Irish population. Eur Respir J 2012; 40: Suppl. 56, 2273

Member's Comments

No comment yet.

Related content which might interest you: Characteristics of zz alpha-1 antitrypsin deficiency patients on the Irish national registry Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 The Irish national alpha-1 antitrypsin deficiency targeted detection programme Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 The national alpha-1 antitrypsin deficiency registry in Poland Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 Rare alpha-1 antitrypsin mutations in the Irish population Source: Annual Congress 2011 - Genetic and environmental risk factors for respiratory diseases Year: 2011 Rare alpha-1 antitrypsin mutations in the Irish population Source: Annual Congress 2012 - COPD inflammation and genes Year: 2012 Pilot study for detection of alpha-1 antitrypsin deficiency in a targeted Argentinean population Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 Clinical features of alpha one antitrypsin deficiency in COPD Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015 Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011 Implementation of screening program for alpha-1 antitrypsin deficiency in Spain Source: Annual Congress 2004 - Emphysema and oxygen therapy Year: 2004 The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes Source: Eur Respir J, 56 (6) 2001441; 10.1183/13993003.01441-2020 Year: 2020 Alpha-1 antitrypsin deficiency severity and the risk of COVID-19 Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19 Year: 2021 Degree of knowledge among physicians about the diagnosis and treatment of alpha-1 antitrypsin deficiency Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Clinical and functional characteristics of Italian and Spanish patients with alpha 1-antitrypsin deficiency Source: Annual Congress 2012 - COPD: epidemiology and varia Year: 2012 Screening of alpha-1 antitrypsin deficiency in a blood donors cohort of the North-Italian area Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 Diagnosing alpha-1 antitrypsin deficiency in Romania - first 1000 cases tested Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement? Year: 2020 Diagnosis of alpha 1 antitrypsin deficiency in primary care Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015 Alpha-1 antitrypsin deficiency in patients with bronchiectasis: data from the European Bronchiectasis Registry EMBARC Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Alpha-1 antitrypsin deficiency and lung cancer: Description of a cohort of patients in northwestern Spain Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021 A well-designed/conducted study on alpha-1 antitrypsin epidemiology not quoted Source: Eur Respir J, 51 (3) 1702662; 10.1183/13993003.02662-2017 Year: 2018